The drug is already used to treat several autoimmune diseases, including rheumatoid arthritis, ulcerative colitis, and ...

In 2023, the groundbreaking Australian BANDIT (Baricitinib in New Onset Type 1 Diabetes) trial reported that a daily pill of ...

After receiving conflicting diagnoses for an autoimmune disorder, Miem van Vuuren hopes to consult a private doctor but requires financial support from the community.

The disease-modifying pill could, used early enough, allow people with type 1 diabetes to be significantly less dependent on insulin treatment.

The effects of the JAK inhibitor baricitinib (Olumiant) waned after treatment was stopped among patients with new-onset type ...

Baltimore is really becoming a big name in biotech. Lots of companies here are working on new ways to help people with their ...

The Advisory Committee on Immunization Practices may vote to disrupt the childhood vaccine schedule, despite what experts say ...

Michelle Newmark has tried — and failed — a couple times to get an updated COVID-19 vaccine. First, she was told she needed a ...